Table 2.
HA-modified nanoplatforms for photothermal chemotherapy.
| NIR-Responsive Materials | Molecular Weight of HA | Chemotherapeutic Drugs | Cell Line | Status | Ref. |
|---|---|---|---|---|---|
| ICG | 10 KDa | DOX | HCT-116 | In vivo | [93] |
| Gold nanorods | 8000 Da | DOX | MCF-7 | In vivo | [96] |
| 190,000 | DOX | SKOV-3 (human ovarian cancer), HOSEpiC (human ovarian surface epithelial cell) | In vitro | [99] | |
| 5000 Da | DOX | MCF-7, MCF-7 ADR (drug-resistant human breast adenocarcinoma) | In vitro | [100] | |
| Polypyrrole | 200 kDa | Docetaxel (DTX) | 4T1 (mouse breast cancer) | In vivo | [105] |
| PB NPs | 32 k | 10-hydroxycamptothecin | HeLa | In vivo | [107] |
| Graphene oxide | 10,000 | DOX | SKOV-3 (human ovarian cancer) | In vitro | [112] |
| 7000 kDa | DOX | A549 | In vivo | [102] |